Ketamine in Bariatric Surgery

Phase 3UnknownNCT01724983

University of Padova90 enrolled

Overview

Ketamine may improve recovery from bariatric surgery.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Morbid Obesity

Interventions

ketamineDRUG

fentanylDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * age \> 18 * obesity (Body Mass Index \> 30) * ASA classificazion \< 4 * candidate to bariatric surgery Exclusion Criteria: * known or presumed pregnancy * previous surgery on the airway, esophagus or stomach * uncontrolled psychiatric symptomatology

Locations (1)

Azienda Ospedaliera

Padova, PD, Italy

Outcomes

Primary Outcomes

pain level

Time frame: postoperatively, up to 3 months

mood level

Time frame: postoperatively, up to 3 months

Secondary Outcomes

total dosages of analgesic and muscle relaxant drugs

Time frame: postoperatively, up to 3 months

postanesthetic recovery

Time frame: postoperatively, up to 24 hours

satisfaction of the patient and of the surgeon

Time frame: day 1

pulse oximetry saturation

Time frame: postoperatively, up to 24 hours

lung volumes

Time frame: postoperatively, up to 48 hours from end of surgery

antihemetic drug dosage

Time frame: postoperatively, up to 24 hours

vasoactive drugs

Time frame: intraoperatively and up to 24 hours from surgery end

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.